Researchers identify blood biomarkers that may help diagnose, confirm concussions

April 20, 2018, University of California, Irvine
Credit: CC0 Public Domain

Researchers from the University of California, Irvine, Georgetown University and the University of Rochester have found that specific small molecules in blood plasma may be useful in determining whether someone has sustained a mild traumatic brain injury (mTBI), commonly known as a concussion. The article, "Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls," is now online at the PLOS One.

Six specific from were discovered in a group of college athletes who had been diagnosed with concussions. When these were assessed, their combined presence accurately predicted whether teammates had sustained an mTBI or not. This suggests that these small molecules, and possibly others, might be clinically relevant biomarkers of mTBI. The same six biomarkers were then tested in a separate group of individuals, without and with mTBI, and the results replicated the athlete findings.

Although the results are encouraging, the authors report limitations to their study and recommend additional investigations related to these and other mTBI biomarkers in blood that will further clarify their utility in clinical management.

"Such blood tests are important in determining not only whether someone has sustained a concussion, which is not currently an easy task, but may eventually prove useful in defining when injured individuals may be eligible to safely return to regular activities," said Massimo S. Fiandaca, MD, the paper's first author, a retired neurosurgeon and co-director of the Georgetown and UCI research groups led by the paper's senior author, Howard J. Federoff, MD, PhD.

An objective of mTBI is not yet available to healthcare providers, coaches and trainers, and military commanders and combat medics. Such a diagnostic test might revolutionize the management of civilian and military concussions, including strategies to avoid post-concussive complications and more severe consequences, such as . Researchers at UCI are helping advance technologies and therapeutic approaches that may benefit all societies, but are directly relevant to their local populations.

The estimated 40 million individuals worldwide diagnosed with mTBI likely represent a gross underestimation of those actually sustaining such injuries. Clinical practitioners require a relevant and reliable, minimally invasive, objective diagnostic test to determine high versus low probability of mTBI in a timely manner.

Fiandaca said there is a clear need to improve diagnostic capabilities, which could reduce underreporting of mTBI and allow more appropriate care to be delivered to concussed individuals. Falls represent the most common cause associated with mTBI among civilians in the United States and around the world. In the U.S., sport-related mTBI produces up to 3.8 million documented injuries per year. Changes in warfare practices in the last two decades have elevated blast (i.e., explosive) injuries to the primary cause for mTBI in the US active duty military. Between 2000-2016 approximately 82% of all military TBI fell into this category.

Although current technologies for defining the discovered small molecules in today's publication lack the rapid, point-of-care platforms being developed for other measures, the study authors anticipate a growing technological momentum to develop such novel platforms resulting from this and similar investigations.

Explore further: New study shows GFAP and UCH-L1 are not useful biomarkers for diagnosing mild traumatic brain injury

More information: Massimo S. Fiandaca et al, Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls, PLOS ONE (2018). DOI: 10.1371/journal.pone.0195318

Related Stories

New study shows GFAP and UCH-L1 are not useful biomarkers for diagnosing mild traumatic brain injury

February 7, 2017
In patients who suffered acute orthopedic injuries, two proposed biomarkers for mild traumatic brain injury (mTBI) were not able to distinguish between patients who did or did not have mTBI. Relying on elevated levels of ...

MRI shows 'brain scars' in military personnel with blast-related concussion

December 15, 2015
MRI shows brain damage in a surprisingly high percentage of active duty military personnel who suffered blast-related mild traumatic brain injury (MTBI), according to a new study appearing online in the journal Radiology.

Brain abnormalities found among those experiencing blast-related mild traumatic brain injury

April 22, 2015
Individuals with mild Traumatic Brain Injury (mTBI), particularly those who have had loss of consciousness (LOC), show structural brain abnormalities in their white matter as measured by Diffusion Tensor Imaging (DTI).

Concussion can now be diagnosed with 95 percent specificity

October 4, 2016
A team of researchers from the University of Miami Miller School of Medicine has shown that the I-Portal Neuro Otologic Test, which uses the head-mounted goggle that gauged eye movement through video cameras and computers, ...

Depression in soldiers linked to brain disruption from injury

November 29, 2016
Using multiple brain imaging techniques, researchers have found that a disruption of the circuitry in the brain's cognitive-emotional pathways may provide a physical foundation for depression symptoms in some service members ...

Recommended for you

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

Study may offer doctors a more effective way to treat neuroblastoma

December 7, 2018
A very large team of researchers, mostly from multiple institutions across Germany, has found what might be a better way to treat patients with neuroblastoma, a type of cancer. In their paper published in the journal Science, ...

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

'Chemo brain' caused by malfunction in three types of brain cells, study finds

December 6, 2018
More than half of cancer survivors suffer from cognitive impairment from chemotherapy that lingers for months or years after the cancer is gone. In a new study explaining the cellular mechanisms behind this condition, scientists ...

Hybrid prevalence estimation: Method to improve intervention coverage estimations

December 6, 2018
LSTM's Professor Joseph Valadez is senior author on a new study published today in the Proceedings of the National Academy of Sciences, which outlines proposals for a more accurate estimator of health data.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.